1. Roscovitine: A Highly Selective CDK Inhibitor With Promising Oncology

    (R)-Roscovitine is often referred to as a “selective inhibitor of cyclin-dependent kinases.” Besides its use as a biological tool in cell cycle, neuronal functions, and apoptosis studies, it is currently evaluated as a potential drug to treat cancers, neurodegenerative diseases, viral infections, and glomerulonephritis.

1 Item

To Top